Ahmad Doroudian

Ahmad Doroudian

Vorstandsvorsitzender bei BETTERLIFE PHARMA INC.

Vermögen: 2 Mio $ am 30.06.2026

65 Jahre
Health Technology
Finance
Consumer Services

Profil

Ahmad Doroudian was the founder of Silvio Ventures, Inc., founded in 1996, and served as Vice Chairman in 2004.
Dr. Doroudian was the founder of BetterLife Pharma, Inc., founded in 2007, and served as Chairman & Secretary from 2015 to 2018.
Dr. Doroudian was the founder of Merus Labs, Inc., founded in 2009, and served as President, Chief Executive Officer & Director from 2011 to 2014.
Dr. Doroudian was the founder of Merus Labs International, Inc., founded in 2011, and served as Chief Executive Officer & Director from 2012 to 2013.
Dr. Doroudian was the founder of Pangeo (USA) Corp., founded in 1994, and served as Chief Executive Officer from 1994 to 2002.
Dr. Doroudian is also the founder of MedMelior, Inc...
Dr. Doroudian is currently Chief Executive Officer at BetterLife Pharma, Inc. since 2026.
Dr. Doroudian is currently Director at 6708595 Canada, Inc. Former positions included President, Chief Executive Officer & Director at Merus Labs International, Inc. from 2010 to 2011; Chief Executive Officer at ABF Pharmaceutical Services GmbH in 2008; President, Chief Executive Officer & Director at Vansen Pharma, Inc. in 2014; Operations Manager at Novapharm Ltd from 1990 to 1996; and President at Rayan Pharma, Inc. in 2007.
Education includes undergraduate, graduate, and doctorate degrees from the University of British Columbia.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
23.06.2026 17.764.338 ( 10,98 % ) 2 Mio $ 30.06.2026

Aktive Positionen von Ahmad Doroudian

UnternehmenPositionBeginn
BETTERLIFE PHARMA INC. Vorstandsvorsitzender 20.01.2020
Direktor/Vorstandsmitglied -
Gründer -

Ehemalige bekannte Positionen von Ahmad Doroudian

UnternehmenPositionEnde
BETTERLIFE PHARMA INC. Vorstandsvorsitzender 20.11.2015
VANSEN PHARMA INC. Vorstandsvorsitzender 21.11.2014
Gründer 01.02.2014
Präsident 19.12.2011
Präsident 01.01.2008
Sehen Sie sich die Erfahrung von Ahmad Doroudian im Detail an

Ausbildung von Ahmad Doroudian

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

38

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Rayan Pharma, Inc.

Health Technology

Health Technology

Health Technology

Pangeo (USA) Corp.

Producer Manufacturing

Retail Trade

Health Technology

  1. Börse
  2. Insiders
  3. Ahmad Doroudian